Zhejiang Jinhua CONBA Pharmaceutical

Zhejiang Jinhua CONBA Bio-Pharm Co., Ltd. is a prominent subsidiary of the Zhejiang CONBA Pharmaceutical Group, specializing in the development and large-scale manufacturing of Active Pharmaceutical Ingredients (APIs) and finished dosage forms. Founded in 1958 and based in Jinhua, China, the company operates multiple GMP-certified production lines for powders, tablets, capsules, and lyophilized injections. Its extensive product portfolio covers therapeutic areas such as anti-infectives, gastroenterology, cardiovascular health, and neurology, with flagship products including Amikacin and Omeprazole. The company serves as a key manufacturing hub for the broader CONBA Group and maintains a significant international footprint, exporting to over 60 countries. As a major player in the Chinese pharmaceutical industry, it integrates traditional chemical synthesis with modern biotechnology to support both proprietary products and contract manufacturing services.